The event Specialty Pharmaceuticals–Licensing & IP Strategies for Faster Value Creation will be held on Tuesday, March 14, 2006 from 6 to 8 p.m. at the Marriott La Jolla, Salons A & B, 4240 La Jolla Village Drive, San Diego. The program will examine the next step for the specialty pharma business model. Speakers will include Laurent Fischer, President & CEO of Ocera Therapeutics; Bob More, Partner of Domain Associates; Karen Dow, Partner at Townsend and Townsend and Crew LLP; and Richard K. Masterson Jr., VP of Global Commercial Development at Valeant Pharmaceuticals International. The moderator is David Palella, President of BioScience Ventures, Inc.